![Robert Francomano](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Robert M.
Francomano served as the Chief Commercial Officer at Stemline Therapeutics, Inc. from 2016 to 2021.
He then held the position of Chief Commercial Officer & Senior Vice President at SELLAS Life Sciences Group, Inc. from 2022 to 2024.
Prior to his roles in the pharmaceutical industry, he obtained an undergraduate degree from Siena College and an MBA from the University of Albany.
Anciens postes connus de Robert Francomano
| Sociétés | Poste | Fin |
|---|---|---|
| SELLAS LIFE SCIENCES GROUP, INC. | Corporate Officer/Principal | 31/03/2024 |
| STEMLINE THERAPEUTICS, INC. | Corporate Officer/Principal | 01/12/2021 |
Formation de Robert Francomano
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
4
Relations au 1er degré
4
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Stemline Therapeutics, Inc.
 Stemline Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel oncology therapeutics | Health Technology |
Siena College
 Siena College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
SELLAS Life Sciences Group, Inc.
 SELLAS Life Sciences Group, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceuticals | Health Technology |
University of Albany
 University of Albany Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
